Results 241 to 250 of about 54,207 (313)

Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib [PDF]

, 2011
Melissa L. Johnson, Greg J. Riely, Naiyer A. Rizvi, Christopher G. Azzoli, Mark G. Kris, Camelia S. Sima, Michelle S. Ginsberg, William Pao, Vincent A. Miller   +8 more
openalex   +1 more source

Dasatinib-Induced Pulmonary Arterial Hypertension in Chronic Myeloid Leukaemia: A Case Report and Literature Review. [PDF]

Respirol Case Rep
Krishnan S, Adigopula S.
europepmc   +1 more source

Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium [PDF]

, 2011
Manish Sharma, Kristen Wroblewski, Blasé N. Polite, James A. Knost, James A. Wallace, Sanjiv Modi, Bethany Sleckman, David Taber, Everett E. Vokes, Walter M. Stadler, Hedy L. Kindler   +10 more
openalex   +1 more source

Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results. [PDF]

Leukemia
Cortes JE, Lang F, Rea D, Hochhaus A, Breccia M, Goh YT, Heinrich MC, Hughes TP, Janssen JJWM, le Coutre P, Minami H, Sasaki K, DeAngelo DJ, Sanchez-Olle G, Pognan N, Cao M, Hoch M, Mauro MJ.   +17 more
europepmc   +1 more source

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma [PDF]

, 2011
Alain P. Algazi, Jeffrey S. Weber, Stephanie Andrews, P. Urbas, Pamela N. Münster, Ronald C. DeConti, Justin H. Hwang, Vernon K. Sondak, Jane L. Messina, Timothy H. McCalmont, Adil Daud   +10 more
openalex   +1 more source

Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.

JAMA Oncol
Zhang M, Fu S, Feng J, Hong R, Wei G, Zhao H, Zhao M, Xu H, Cui J, Huang S, Wu X, Liu L, Sun J, Wu W, Zhu Y, He J, Zhao Y, Cai Z, Zheng W, Ye X, Shi J, Luo Y, Wang D, Chang AH, Hu Y, Huang H.   +25 more
europepmc   +1 more source

Estimation of Absolute Binding Free Energies for Drugs That Bind Multiple Proteins. [PDF]

J Chem Inf Model
Lindahl E, Friedman R.
europepmc   +1 more source

Current Advances in the Diagnosis and Treatment of Major Myeloproliferative Neoplasms. [PDF]

Cancers (Basel)
Wang L, Li J, Arbitman L, Zhang H, Shao H, Martin M, Moscinski L, Song J.   +7 more
europepmc   +1 more source

First-Line Dasatinib Superior to Imatinib in Chronic Phase Chronic Myelogenous Leukemia

, 2010
Robert H. Carlson
openalex   +1 more source

Molecular response of a patient with e19a2-positive chronic myeloid leukemia to flumatinib: a case report and literature review. [PDF]

Front Med (Lausanne)
Feng Y, Wang H, Zhang L, Gong J, Liu X, Mu C, Qiao J, Meng H, Zhang Y.   +8 more
europepmc   +1 more source